Bettina

The RESIST members' meeting on 17 April 2024 in Lecture Hall Q, which was attended by around 30 members and in which other members took part online, provided an opportunity to meet again, catch up and exchange ideas. During the meeting, Prof Schulz reported that a member of the RESIST Board, Prof Grünewald, had resigned from the Board. Prof Dölken was elected to the Board by the members during the meeting. The next item on the agenda was the election of the RESIST spokesperson and a deputy spokesperson for the period until the end of 2024. The members elected [...]

We welcome Professor Dr. Lars Dölken as a new member of RESIST. The specialist in herpes viruses has been Director of the MHH Institute of Virology since 2 April 2024, succeeding Prof. Schulz, who has headed the institute since 2000. Prof Dölken has also been a member of the RESIST Board since mid-April. Prof. Dölken is a specialist in microbiology, virology and infection biology. The 47-year-old was previously Director of the Institute of Virology and Immunobiology at the Julius-Maximilians-Universität Würzburg. Through the DFG research group FOR2830 "Advanced concepts in the cellular immune control of cytomegaloviruses", which he heads, he [...]

The RESIST speaker trio was delighted to welcome a distinguished visitor: Falko Mohrs, Lower Saxony's Minister for Science and Culture, visited the MHH on 21 March to find out more about our Cluster of Excellence RESIST. Prof Manns received the Minister as well as Julia Streuer, Leon Schmalstieg and Katharina Pfeiffer in the Senate meeting room, together with Dr. Faber from the RESIST management team and the scientists Prof. Lauber, Dr. Jacobsen, Dr. Riemann and Marie-Sophie Schulze. The Minister and his team watched the VR film on the herpes virus infection, had Prof. Schulz, Prof. Hansen and Prof. Förster [...]

Do I need a visa? Where can I live? What insurance do I need to take out? Numerous questions arise when you come to RESIST in Hannover from abroad to do research here. For a first introduction to many of these topics, there is now a lot of information on our RESIST homepage. We would like to make it a little easier for all scientists to get off to a good start. We are delighted that you, as a professor or (post) doctoral student, have decided to conduct research in our international and committed team. Please take a look [...]

If people frequently have severe and protracted infections, an inborn error of immunity may be the cause. To date, almost 500 genes have been found that are associated with such immune deficiencies. However, there is as yet no publicly accessible platform containing comprehensive and up-to-date information on these genes, the mechanisms that cause them and their consequences for humans. RESIST Professor Dr. Michele Proietti and Dr. Andrés Caballero-Oteyza from the MHH Department of Immunology and Rheumatology and the Center for Chronic Immunodeficiency (CCI) in Freiburg, together with other scientists, are currently establishing such a database. The "Genetic Immunology Advisor [...]

Prof. Lachmann receives "ERC Proof of Concept Grant" from the EU for the further development of a novel immune cell therapy Treating bacterial pneumonia with healthy macrophages – that is the goal of the team led by Prof. Lachmann. The European Union (EU) has now awarded his "iMAClung" project, with which he is taking the next steps towards the application of immune cell therapy, an "ERC Proof-of-Concept Grant". Prof. Lachmann holds his professorship at the MHH as part of RESIST. He works in the Department of Pediatric Pneumology, Allergology and Neonatology at MHH. Until now, bacterial pneumonia has mainly [...]